avatar for Samuel Rigourd

Samuel Rigourd

Alnylam Pharmaceuticals
Senior Director Regulatory Affairs
Samuel Rigourd joined Alnylam Pharmaceuticals in 2016 as Senior Director of Regulatory Affairs, where he leads the global registration strategy of a new class of medicines, RNA interference therapeutics. He has over 15 years of experience in regulatory affairs, in various roles both in Europe and US, from managing the regulatory strategy of early and late stage development programs to global labeling. He graduated as Pharmacist from Rennes University of Pharmacy and holds a Master's degree in Regulatory Affairs from Paris XI University of Pharmacy, in France.